Proteasome allostery as a population shift between interchanging conformers

Protein degradation plays a critical role in cellular homeostasis, in regulating the cell cycle, and in the generation of peptides that are used in the immune response. The 20S proteasome core particle (CP), a barrel-like structure consisting of four heptameric protein rings stacked axially on top of each other, is central to this process. CP function is controlled by activator complexes that bind 75 Å away from sites catalyzing proteolysis, and biochemical data are consistent with an allosteric mechanism by which binding is communicated to distal active sites. However, little structural evidence has emerged from the high-resolution images of the CP. Using methyl TROSY NMR spectroscopy, we demonstrate that in solution, the CP interconverts between multiple conformations whose relative populations are shifted on binding of the 11S activator or mutation of residues that contact activators. These conformers differ in contiguous regions of structure that connect activator binding to the CP active sites, and changes in their populations lead to differences in substrate proteolysis patterns. Moreover, various active site modifications result in conformational changes to the activator binding site by modulating the relative populations of these same CP conformers. This distribution is also affected by the binding of a small-molecule allosteric inhibitor of proteolysis, chloroquine, suggesting an important avenue in the development of therapeutics for proteasome inhibition.

[1]  A. Goldberg,et al.  Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. , 2005, Methods in enzymology.

[2]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[3]  L. Kay,et al.  Probing supramolecular structure from measurement of methyl (1)H-(13)C residual dipolar couplings. , 2007, Journal of the American Chemical Society.

[4]  L. Kay,et al.  Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR , 2010, Science.

[5]  S. Ōmura,et al.  Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System , 1997, The Journal of experimental medicine.

[6]  R. Dohmen,et al.  Catalytic mechanism and assembly of the proteasome. , 2009, Chemical reviews.

[7]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[8]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[9]  L. Kay,et al.  Cross-correlated relaxation enhanced 1H[bond]13C NMR spectroscopy of methyl groups in very high molecular weight proteins and protein complexes. , 2003, Journal of the American Chemical Society.

[10]  A. Bax Weak alignment offers new NMR opportunities to study protein structure and dynamics , 2003, Protein science : a publication of the Protein Society.

[11]  M. Glickman,et al.  Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites , 2007, Nature Structural &Molecular Biology.

[12]  A. Goldberg,et al.  Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.

[13]  H. Holzhütter,et al.  Evidence for the Existence of a Non-catalytic Modifier Site of Peptide Hydrolysis by the 20 S Proteasome* , 2000, The Journal of Biological Chemistry.

[14]  L. Kay,et al.  Effect of noncompetitive proteasome inhibition on bortezomib resistance. , 2010, Journal of the National Cancer Institute.

[15]  K. Ferrell,et al.  Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators* , 2009, The Journal of Biological Chemistry.

[16]  L. Masterson,et al.  cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban. , 2011, Journal of molecular biology.

[17]  Lila M. Gierasch,et al.  Allosteric signal transmission in the nucleotide-binding domain of 70-kDa heat shock protein (Hsp70) molecular chaperones , 2011, Proceedings of the National Academy of Sciences.

[18]  S. Chatterjee,et al.  Applications of saturation transfer difference NMR in biological systems. , 2012, Drug discovery today.

[19]  Giuseppe Melacini,et al.  Mapping allostery through the covariance analysis of NMR chemical shifts , 2011, Proceedings of the National Academy of Sciences.

[20]  Yifan Cheng,et al.  Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.

[21]  M. Bogyo,et al.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta. , 2001, EMBO Journal.

[22]  Yifan Cheng Toward an atomic model of the 26S proteasome. , 2009, Current opinion in structural biology.

[23]  K. Lindsten,et al.  Lack of proteasome active site allostery as revealed by subunit-specific inhibitors. , 2001, Molecular cell.

[24]  Keiji Tanaka,et al.  Double‐cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  K. Sadre-Bazzaz,et al.  Structure of a Blm10 complex reveals common mechanisms for proteasome binding and gate opening. , 2010, Molecular cell.

[26]  C. Hill,et al.  Purification and analysis of recombinant 11S activators of the 20S proteasome: Trypanosoma brucei PA26 and human PA28 alpha, PA28 beta, and PA28 gamma. , 2005, Methods in enzymology.

[27]  C. Hill,et al.  Proteasome activators. , 2011, Molecular cell.

[28]  M. Groll,et al.  Exploiting nature's rich source of proteasome inhibitors as starting points in drug development. , 2012, Chemical communications.

[29]  M. Bogyo,et al.  Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β , 2001 .

[30]  L. Kay,et al.  The proteasome antechamber maintains substrates in an unfolded state , 2010, Nature.

[31]  D E Wemmer,et al.  Two-state allosteric behavior in a single-domain signaling protein. , 2001, Science.

[32]  Yifan Cheng,et al.  Interactions of PAN's C‐termini with archaeal 20S proteasome and implications for the eukaryotic proteasome–ATPase interactions , 2010, The EMBO journal.

[33]  M. Hochstrasser,et al.  A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. , 2009, Structure.

[34]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[35]  B. Meyer,et al.  Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes. , 2005, Journal of the American Chemical Society.

[36]  Lewis E. Kay,et al.  Quantitative dynamics and binding studies of the 20S proteasome by NMR , 2007, Nature.

[37]  C. Hill,et al.  The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. , 2005, Molecules and Cells.

[38]  M. Rechsteiner,et al.  The proteasome activator 11 S REG (PA28) and class I antigen presentation. , 2000, The Biochemical journal.

[39]  W Keilholz,et al.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Soyeon Park,et al.  Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. , 2007, Molecular cell.

[41]  M. Rechsteiner,et al.  Substrate specificity of the human proteasome. , 2001, Chemistry & biology.

[42]  S. Tzeng,et al.  Protein activity regulation by conformational entropy , 2012, Nature.

[43]  L. Kay,et al.  Novel proteasome inhibitors to overcome bortezomib resistance. , 2011, Journal of the National Cancer Institute.

[44]  G. Amarasinghe,et al.  Internal dynamics control activation and activity of the autoinhibited Vav DH domain , 2008, Nature Structural &Molecular Biology.

[45]  L. Kay,et al.  Solution NMR of supramolecular complexes: providing new insights into function , 2007, Nature Methods.

[46]  L. Kay,et al.  TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. , 2008, Biochemistry.

[47]  P. Osmulski,et al.  Nanoenzymology of the 20S proteasome: proteasomal actions are controlled by the allosteric transition. , 2002, Biochemistry.

[48]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[49]  J. Cavanagh Protein NMR Spectroscopy: Principles and Practice , 1995 .

[50]  M. Hochstrasser,et al.  A Conserved 20S Proteasome Assembly Factor Requires a C-terminal HbYX Motif for Proteasomal Precursor Binding , 2011, Nature Structural &Molecular Biology.

[51]  L. Kay,et al.  Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy , 2006, Nature Protocols.